Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ACE-031 for the Treatment of Duchenne Muscular Dystrophy

DMD occurs due to the genetic mutations that can result in the absence or defect of protein called dystrophin.

Go Top